These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 19179419

  • 1. Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.
    Crawford MA, Zhu Y, Green CS, Burdick MD, Sanz P, Alem F, O'Brien AD, Mehrad B, Strieter RM, Hughes MA.
    Infect Immun; 2009 Apr; 77(4):1664-78. PubMed ID: 19179419
    [Abstract] [Full Text] [Related]

  • 2. Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.
    Crawford MA, Burdick MD, Glomski IJ, Boyer AE, Barr JR, Mehrad B, Strieter RM, Hughes MA.
    PLoS Pathog; 2010 Nov 18; 6(11):e1001199. PubMed ID: 21124994
    [Abstract] [Full Text] [Related]

  • 3. Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis.
    Crawford MA, Lowe DE, Fisher DJ, Stibitz S, Plaut RD, Beaber JW, Zemansky J, Mehrad B, Glomski IJ, Strieter RM, Hughes MA.
    Proc Natl Acad Sci U S A; 2011 Oct 11; 108(41):17159-64. PubMed ID: 21949405
    [Abstract] [Full Text] [Related]

  • 4. CXCL10 Acts as a Bifunctional Antimicrobial Molecule against Bacillus anthracis.
    Margulieux KR, Fox JW, Nakamoto RK, Hughes MA.
    mBio; 2016 May 10; 7(3):. PubMed ID: 27165799
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino SI.
    Microbiology (Reading); 2006 Oct 10; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.
    Louie A, VanScoy BD, Brown DL, Kulawy RW, Heine HS, Drusano GL.
    Antimicrob Agents Chemother; 2012 Mar 10; 56(3):1229-39. PubMed ID: 22155821
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.
    Heine HS, Bassett J, Miller L, Purcell BK, Byrne WR.
    Antimicrob Agents Chemother; 2010 Oct 10; 54(10):4471-3. PubMed ID: 20643899
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
    Jang J, Cho M, Lee HR, Cha K, Chun JH, Hong KJ, Park J, Rhie GE.
    Biochim Biophys Acta; 2013 Mar 10; 1830(3):2804-12. PubMed ID: 23201204
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model.
    Cote CK, Bozue J, Twenhafel N, Welkos SL.
    J Med Microbiol; 2009 Jun 10; 58(Pt 6):816-825. PubMed ID: 19429760
    [Abstract] [Full Text] [Related]

  • 16. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
    Cybulski RJ, Sanz P, McDaniel D, Darnell S, Bull RL, O'Brien AD.
    Vaccine; 2008 Sep 08; 26(38):4927-39. PubMed ID: 18657585
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human lung innate immune response to Bacillus anthracis spore infection.
    Chakrabarty K, Wu W, Booth JL, Duggan ES, Nagle NN, Coggeshall KM, Metcalf JP.
    Infect Immun; 2007 Aug 08; 75(8):3729-38. PubMed ID: 17517878
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of spore germination in a mouse model of cutaneous anthrax.
    Bischof TS, Hahn BL, Sohnle PG.
    J Infect Dis; 2007 Mar 15; 195(6):888-94. PubMed ID: 17299720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.